Susan Garl
About
In The Last Decade
Susan Garl
8 papers receiving 397 citations
Peers
Comparison fields: 5 of 63
- Molecular Biology 177
- Immunology 162
- Oncology 139
- Hematology 79
- Biochemistry 46
Countries citing papers authored by Susan Garl
This map shows the geographic impact of Susan Garl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Garl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Garl more than expected).
Fields of papers citing papers by Susan Garl
This network shows the impact of papers produced by Susan Garl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Garl. The network helps show where Susan Garl may publish in the future.
Co-authorship network of co-authors of Susan Garl
This figure shows the co-authorship network connecting the top 25 collaborators of Susan Garl. A scholar is included among the top collaborators of Susan Garl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Garl. Susan Garl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | A phase-I study of 90Y-hPAM4 (humanized anti-MUC1 monoclonal antibody) in patients with unresectable and metastatic pancreatic cancer | 4 |
| 2 | 20 | |
| 3 | 36 | |
| 4 | 128 | |
| 5 | 181 | |
| 6 | 1 | |
| 7 | Long-term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: a non-anthracycline containing regimen. | 31 |
| 8 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.